Concord Interest Income from 2010 to 2026

CCM Stock

USD 3.64 0.14 4.00%

Concord Medical Interest Income yearly trend continues to be very stable with very little volatility. Interest Income is likely to grow to about 17.4 M this year. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2010-12-31

Previous Quarter

12.6 M

Current Value

17.4 M

Quarterly Volatility

17.7 M

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Concord Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concord Medical's main balance sheet or income statement drivers, such as Interest Expense of 233.3 M, Selling General Administrative of 488.3 M or Total Revenue of 417.7 M, as well as many indicators such as Price To Sales Ratio of 0.0163, Dividend Yield of 5.83 or Days Sales Outstanding of 53.14. Concord financial statements analysis is a perfect complement when working with Concord Medical Valuation or Volatility modules.

Build AI portfolio with Concord Stock

Check out the analysis of Concord Medical Correlation against competitors.

Evaluating Concord Medical's Interest Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Concord Medical Services's fundamental strength.

Latest Concord Medical's Interest Income Growth Pattern

Below is the plot of the Interest Income of Concord Medical Services over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Concord Medical's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Concord Medical's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Concord Interest Income Regression Statistics

	Arithmetic Mean	16,864,454
	Geometric Mean	12,414,827
	Coefficient Of Variation	105.14
	Mean Deviation	11,843,306
	Median	10,021,000
	Standard Deviation	17,730,637
	Sample Variance	314.4T
	Range	66.5M
	R-Value	0.02
	Mean Square Error	335.2T
	R-Squared	0.0004
	Significance	0.94
	Slope	72,921
	Total Sum of Squares	5030T

Concord Interest Income History

	2026	17.4 M
	2025	12.6 M
	2024	14 M
	2023	10.8 M
	2022	10 M
	2021	5.9 M
	2020	8.4 M

Other Fundumenentals of Concord Medical Services

Net Interest Income

Concord Medical Interest Income component correlations

	Total Assets	Total Stockholder Equity	Long Term Debt	Good Will	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Short Term Debt	Short Term Investments	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.69	0.79	0.74	0.82	0.74	0.66	0.81	0.69	0.81	-0.81	0.64	-0.32	-0.09	0.47	0.01	-0.64	-0.82	0.34	0.48	-0.01	0.79	0.72	0.01	-0.75	-0.59	-0.19
Total Stockholder Equity	-0.69		-0.93	-0.78	-0.85	-0.57	-0.07	-0.94	-0.72	-0.88	0.96	-0.65	0.75	0.5	-0.39	0.21	0.68	0.93	-0.3	-0.51	-0.18	-0.93	-0.73	0.14	0.89	0.77	0.42
Long Term Debt	0.79	-0.93		0.84	0.95	0.61	0.33	0.99	0.7	0.97	-0.96	0.75	-0.64	-0.39	0.51	-0.01	-0.68	-0.93	0.39	0.46	0.15	1.0	0.76	-0.12	-0.85	-0.76	-0.58
Good Will	0.74	-0.78	0.84		0.8	0.46	0.32	0.85	0.66	0.86	-0.88	0.89	-0.56	-0.41	0.48	0.12	-0.35	-0.8	0.15	0.42	0.44	0.84	0.42	-0.19	-0.8	-0.77	-0.52
Total Liab	0.82	-0.85	0.95	0.8		0.59	0.47	0.94	0.56	0.98	-0.9	0.8	-0.59	-0.16	0.72	0.1	-0.69	-0.86	0.37	0.52	0.22	0.95	0.79	-0.14	-0.79	-0.8	-0.64
Intangible Assets	0.74	-0.57	0.61	0.46	0.59		0.42	0.62	0.58	0.53	-0.59	0.3	-0.24	-0.09	0.1	-0.25	-0.77	-0.64	0.31	0.46	-0.26	0.61	0.77	0.24	-0.66	-0.17	-0.1
Common Stock	0.66	-0.07	0.33	0.32	0.47	0.42		0.35	0.2	0.41	-0.28	0.28	0.18	0.31	0.4	0.33	-0.38	-0.34	0.2	0.16	-0.17	0.33	0.43	-0.01	-0.29	-0.21	-0.16
Property Plant Equipment	0.81	-0.94	0.99	0.85	0.94	0.62	0.35		0.71	0.96	-0.97	0.73	-0.65	-0.43	0.49	-0.06	-0.7	-0.95	0.38	0.45	0.15	0.99	0.77	-0.15	-0.9	-0.78	-0.54
Current Deferred Revenue	0.69	-0.72	0.7	0.66	0.56	0.58	0.2	0.71		0.62	-0.75	0.45	-0.31	-0.38	0.09	-0.38	-0.51	-0.75	0.18	0.48	-0.05	0.7	0.51	0.1	-0.74	-0.33	-0.06
Net Debt	0.81	-0.88	0.97	0.86	0.98	0.53	0.41	0.96	0.62		-0.94	0.84	-0.6	-0.26	0.69	0.07	-0.63	-0.89	0.37	0.48	0.26	0.97	0.73	-0.22	-0.79	-0.84	-0.62
Retained Earnings	-0.81	0.96	-0.96	-0.88	-0.9	-0.59	-0.28	-0.97	-0.75	-0.94		-0.75	0.67	0.43	-0.48	0.08	0.65	0.96	-0.32	-0.51	-0.21	-0.96	-0.72	0.16	0.9	0.82	0.42
Accounts Payable	0.64	-0.65	0.75	0.89	0.8	0.3	0.28	0.73	0.45	0.84	-0.75		-0.51	-0.13	0.72	0.29	-0.21	-0.63	0.13	0.4	0.57	0.75	0.32	-0.18	-0.57	-0.77	-0.63
Net Receivables	-0.32	0.75	-0.64	-0.56	-0.59	-0.24	0.18	-0.65	-0.31	-0.6	0.67	-0.51		0.59	-0.27	0.17	0.49	0.53	-0.16	-0.44	-0.53	-0.64	-0.5	0.14	0.6	0.67	0.43
Total Current Assets	-0.09	0.5	-0.39	-0.41	-0.16	-0.09	0.31	-0.43	-0.38	-0.26	0.43	-0.13	0.59		0.33	0.45	0.23	0.37	-0.09	-0.09	-0.2	-0.39	-0.16	0.34	0.48	0.32	0.12
Short Term Debt	0.47	-0.39	0.51	0.48	0.72	0.1	0.4	0.49	0.09	0.69	-0.48	0.72	-0.27	0.33		0.35	-0.26	-0.38	0.28	0.37	0.43	0.5	0.41	-0.28	-0.25	-0.71	-0.57
Short Term Investments	0.01	0.21	-0.01	0.12	0.1	-0.25	0.33	-0.06	-0.38	0.07	0.08	0.29	0.17	0.45	0.35		0.39	0.11	-0.18	-0.2	0.27	-0.01	-0.26	0.15	0.25	-0.16	-0.38
Treasury Stock	-0.64	0.68	-0.68	-0.35	-0.69	-0.77	-0.38	-0.7	-0.51	-0.63	0.65	-0.21	0.49	0.23	-0.26	0.39		0.67	-0.44	-0.52	0.17	-0.68	-0.97	0.02	0.69	0.37	0.19
Net Tangible Assets	-0.82	0.93	-0.93	-0.8	-0.86	-0.64	-0.34	-0.95	-0.75	-0.89	0.96	-0.63	0.53	0.37	-0.38	0.11	0.67		-0.24	-0.42	0.02	-0.93	-0.72	0.12	0.93	0.72	0.37
Deferred Long Term Liab	0.34	-0.3	0.39	0.15	0.37	0.31	0.2	0.38	0.18	0.37	-0.32	0.13	-0.16	-0.09	0.28	-0.18	-0.44	-0.24		-0.09	-0.27	0.39	0.54	-0.2	-0.2	-0.28	-0.09
Long Term Investments	0.48	-0.51	0.46	0.42	0.52	0.46	0.16	0.45	0.48	0.48	-0.51	0.4	-0.44	-0.09	0.37	-0.2	-0.52	-0.42	-0.09		0.41	0.45	0.52	-0.03	-0.39	-0.34	-0.18
Short Long Term Debt	-0.01	-0.18	0.15	0.44	0.22	-0.26	-0.17	0.15	-0.05	0.26	-0.21	0.57	-0.53	-0.2	0.43	0.27	0.17	0.02	-0.27	0.41		0.15	-0.14	-0.24	-0.03	-0.48	-0.42
Long Term Debt Total	0.79	-0.93	1.0	0.84	0.95	0.61	0.33	0.99	0.7	0.97	-0.96	0.75	-0.64	-0.39	0.5	-0.01	-0.68	-0.93	0.39	0.45	0.15		0.76	-0.12	-0.85	-0.76	-0.58
Capital Surpluse	0.72	-0.73	0.76	0.42	0.79	0.77	0.43	0.77	0.51	0.73	-0.72	0.32	-0.5	-0.16	0.41	-0.26	-0.97	-0.72	0.54	0.52	-0.14	0.76		-0.04	-0.69	-0.49	-0.28
Cash And Equivalents	0.01	0.14	-0.12	-0.19	-0.14	0.24	-0.01	-0.15	0.1	-0.22	0.16	-0.18	0.14	0.34	-0.28	0.15	0.02	0.12	-0.2	-0.03	-0.24	-0.12	-0.04		0.04	0.48	0.09
Net Invested Capital	-0.75	0.89	-0.85	-0.8	-0.79	-0.66	-0.29	-0.9	-0.74	-0.79	0.9	-0.57	0.6	0.48	-0.25	0.25	0.69	0.93	-0.2	-0.39	-0.03	-0.85	-0.69	0.04		0.63	0.37
Net Working Capital	-0.59	0.77	-0.76	-0.77	-0.8	-0.17	-0.21	-0.78	-0.33	-0.84	0.82	-0.77	0.67	0.32	-0.71	-0.16	0.37	0.72	-0.28	-0.34	-0.48	-0.76	-0.49	0.48	0.63		0.49
Capital Stock	-0.19	0.42	-0.58	-0.52	-0.64	-0.1	-0.16	-0.54	-0.06	-0.62	0.42	-0.63	0.43	0.12	-0.57	-0.38	0.19	0.37	-0.09	-0.18	-0.42	-0.58	-0.28	0.09	0.37	0.49

Click cells to compare fundamentals

About Concord Medical Financial Statements

Concord Medical investors utilize fundamental indicators, such as Interest Income, to predict how Concord Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Interest Income	12.6 M	17.4 M
Net Interest Income	-161.3 M	-153.2 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:

How To Invest In Concord

Details

Is Concord Stock a good investment?

Details

What is Concord Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Concord Medical Correlation against competitors.

You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Earnings Share

(5.46)

Revenue Per Share

83.728

Quarterly Revenue Growth

(0.08)

Return On Assets

(0.04)

Return On Equity

(0.29)

Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value - what Concord Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.

It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Concord Interest Income from 2010 to 2026

Latest Concord Medical's Interest Income Growth Pattern

Concord Interest Income Regression Statistics

Concord Interest Income History

Other Fundumenentals of Concord Medical Services

Concord Medical Interest Income component correlations

About Concord Medical Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY